Chassatide C11A

General Information


DRACP ID  DRACP00401

Peptide Name   Chassatide C11A

Sequence  IPCGESCVWIPCISGXFGCSCKDKVCYS

Sequence Length  28

UniProt ID  C0HKH6 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>15 μM MTT assay Not available 1

Hemolytic Activity  Human erythrocytes: HD50>25 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys19; Cys7<--->Cys21; Cys12<--->Cys26

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=MetO (Methionine sulfoxide)

Chiral  L



Physicochemical Information


Formula  C124H188N30O36S6

Absent amino acids  AHLMNQRT

Common amino acids  C

Mass  345918

Pl  6.03

Basic residues  2

Acidic residues  2

Hydrophobic residues  7

Net charge  0

Boman Index  -172

Hydrophobicity  53.93

Aliphatic Index  62.5

Half Life 
  /

Extinction Coefficient cystines  7365

Absorbance 280nm  272.78

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22467870

Title  Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities

Doi 10.1074/jbc.M111.338970

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_4290

DRACP is developed by Dr.Zheng's team.